Multiple Sclerosis News Today Forums › Forums › Treating MS › MS Medications › Complications from Gilenya Treatment Managed Successfully, Case Report Says

  • MS Medications

    Complications from Gilenya Treatment Managed Successfully, Case Report Says

    Posted by MS News Today Moderator on May 18, 2018 at 7:32 am

    A case study reported the successful management of a multiple sclerosis (MS) patient who developed a rare condition in the brain — progressive multifocal leukoencephalopathy (PML) — due to treatment with Novartis Pharmaceutical’s Gilenya (fingolimod).

    The study, titled “Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study,” was published in the journal Neurology Neuroimmunology & Neuroinflammation, and you can read a summary of the research at MultipleSclerosisNewsToday.com: Complications from Gilenya Treatment Managed Successfully, Case Report Says

    What do you think about this news? Have you tried Gilenya?

    replied 5 years, 11 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .